Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 9/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BMP1 | P13497 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21461680 | 0.86 | KCNH2 (0.47) | KCNH2MAPTBMP1RAB9AALDH1A1 | |
| SCHEMBL1350027 | 0.85 | MAPT (0.57) | KCNH2MAPTTSHRRAB9AALDH1A1 | |
| SCHEMBL1350599 | 0.82 | MAPT (0.55) | KCNH2MAPTTSHRRAB9AALDH1A1 | |
| SCHEMBL22838351 | 0.79 | CA12 (0.54) | ALDH1A1 | |
| SCHEMBL6998726 | 0.78 | BMP1 (0.81) | BMP1 | |
| SCHEMBL3534499 | 0.77 | KCNH2 (0.53) | KCNH2MAPTBMP1TSHRRAB9A | |
| SCHEMBL10533251 | 0.77 | NR1D1 (0.57) | KCNH2MAPTTSHRRAB9AALDH1A1 | |
| SCHEMBL1744533 | 0.76 | MAOB (0.64) | KCNH2MAPTALDH1A1PTGS2 | |
| SCHEMBL3157762 | 0.76 | KCNH2 (0.71) | KCNH2TSHR | |
| SCHEMBL9628232 | 0.76 | KCNH2 (0.76) | KCNH2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10806140-B2 | Antimicrobial compound | PHYSICAL SCIENCES, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| US-20190313641-A1 | ANTIMICROBIAL COMPOUND | PHYSICAL SCIENCES, INC. | 2019-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190313641-A1 | ANTIMICROBIAL COMPOUND | NOD2, FPR1, NOD1 | KCNH2 2629/4885MAPT 3792/4885BMP1 1702/4885 |
| US-10806140-B2 | Antimicrobial compound | FPR1, NOD1, NOS1 | KCNH2 2662/4885MAPT 3771/4885BMP1 1067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.